FAM
VTYX

Fred Alger Management’s Ventyx Biosciences VTYX Stock Holding History

Fred Alger Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-216
Closed -$534 – 496
2023
Q4 		$534 Sell
216
-46,428
-100% -$441K ﹤0.01% 442
2023
Q3 		$1.62M Sell
46,644
-13,734
-23% -$475K 0.01% 339
2023
Q2 		$1.98M Sell
60,378
-86,297
-59% -$2.97M 0.01% 337
2023
Q1 		$4.91M Buy
146,675
+118,385
+418% +$4.6M 0.03% 255
2022
Q4 		$928K Buy
28,290
+16,411
+138% +$486K 0.01% 382
2022
Q3 		$415K Buy
+11,879
New +$263K ﹤0.01% 403

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fred Alger Management's VTYX Position: Q1 2024 in Review

Fred Alger Management sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 216 shares — an estimated $534 sold.

Fred Alger Management first reported a position in VTYX in Q3 2022 and held it in 6 quarters. The position peaked at $4.91M in Q1 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Fred Alger Management reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
  • Fred Alger Management sold 216 Ventyx Biosciences shares in Q1 2024, an estimated $534.
  • Fred Alger Management first reported a position in Ventyx Biosciences in Q3 2022 and held it in 6 quarters.
  • Fred Alger Management's Ventyx Biosciences position peaked at $4.91M in Q1 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Fred Alger Management's 13F filing for Q1 2024, filed 15 May 2024.